Justice Department sues Walmart for alleged role in opioid crisis

(Image credit: Getty Images)

The Justice Department on Tuesday sued Walmart, claiming lax oversight in its pharmacies helped fuel the opioid epidemic.

In one of the Trump administration's last shots at big-name facilitators of opioid abuse across the U.S., the DOJ alleged Walmart understaffed its pharmacies to cut costs, The Wall Street Journal reports. In turn, overworked pharmacy staffers didn't catch invalid or otherwise problematic opioid prescriptions they shouldn't have filled, the suit alleges.

While big pharmaceutical companies pressured doctors to dole out painkillers and controlled substances, pharmacies are expected to refuse to fill questionable prescriptions. But understaffing allegedly made this impossible in Walmart's more than 5,000 pharmacies. And as Jason Dunn, the U.S. attorney in Colorado, put it, "Walmart's pharmacies ordered opioids in a way that went essentially unmonitored and unregulated," violating the Controlled Substances Act as early as mid-2013.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.


Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

Walmart had been expecting these charges, and sought to fend them off preemptively with its own lawsuit against the Justice Department in October. Walmart blamed the DOJ's alleged lack of oversight for fueling the opioid epidemic, and sought a reprieve from a judge from any future DOJ lawsuit.

The Trump DOJ had previously settled a massive lawsuit with OxyContin maker Purdue Pharma over its role in the opioid crisis. Hundreds of thousands of people have died from opioid overdoses over the past 20 years. While those numbers have decreased over the past few years, experts give the administration's handling of the crisis mixed reviews.

To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us